Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Celldex Therapeutics
Celldex Therapeutics to Present at the Needham & Company Cancer Therapeutics Conference
April 8th, 2009
Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will present at a the Needham & Company Cancer Therapeutics: Today & Tomorrow conference in New York City on Thursday, March 26, 2009 at 8:40 a.m. Eastern Time. Dr. Davis, presenting on the science behind Celldex’s Precision Targeted Immunotherapy Platform, will be joined by Anthony S. Marucci, President and Chief Executive Officer, and Tibor Keler, Ph.D., Senior Vice President and Chief Scientific Officer of Celldex Therapeutics. An audio only live webcast of the presentation will be available on...
Source: Vaccine Weekly (2009-04-08)
|
